Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.55 Billion CNY | -11.73% |
| 2022 | 1.75 Billion CNY | -0.32% |
| 2021 | 1.76 Billion CNY | -1.75% |
| 2020 | 1.79 Billion CNY | 271.88% |
| 2019 | 482.81 Million CNY | 2454615.09% |
| 2018 | 19.66 Thousand CNY | -100.0% |
| 2017 | 796.47 Million CNY | 0.29% |
| 2016 | 794.18 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 3.26 Million CNY | -0.77% |
| 2010 | 3.28 Million CNY | -51.88% |
| 2009 | 6.83 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.62 Billion CNY | 0.0% |
| 2024 Q3 | 1.61 Billion CNY | -100.0% |
| 2024 Q2 | 1.64 Billion CNY | 0.0% |
| 2023 Q3 | 1.81 Billion CNY | -2.99% |
| 2023 Q4 | 1.55 Billion CNY | -14.25% |
| 2023 Q1 | 1.92 Billion CNY | 9.37% |
| 2023 FY | 1.55 Billion CNY | -11.73% |
| 2023 Q2 | 1.86 Billion CNY | -2.99% |
| 2022 Q1 | 1.83 Billion CNY | 3.76% |
| 2022 FY | 1.75 Billion CNY | -0.32% |
| 2022 Q4 | 1.75 Billion CNY | -5.91% |
| 2022 Q3 | 1.86 Billion CNY | 10.07% |
| 2022 Q2 | 1.69 Billion CNY | -7.24% |
| 2021 Q4 | 1.76 Billion CNY | 10.86% |
| 2021 Q3 | 1.59 Billion CNY | 5.99% |
| 2021 FY | 1.76 Billion CNY | -1.75% |
| 2021 Q1 | 1.46 Billion CNY | -18.6% |
| 2021 Q2 | 1.5 Billion CNY | 2.72% |
| 2020 Q3 | 141.99 Million CNY | -71.29% |
| 2020 FY | 1.79 Billion CNY | 271.88% |
| 2020 Q1 | 489.44 Million CNY | 1.37% |
| 2020 Q2 | 494.56 Million CNY | 1.05% |
| 2020 Q4 | 1.79 Billion CNY | 1164.46% |
| 2019 Q4 | 482.81 Million CNY | -1.43% |
| 2019 FY | 482.81 Million CNY | 2454615.09% |
| 2019 Q1 | 9402.39 CNY | -52.2% |
| 2019 Q2 | 484.13 Million CNY | 5148976.88% |
| 2019 Q3 | 489.83 Million CNY | 1.18% |
| 2018 FY | 19.66 Thousand CNY | -100.0% |
| 2018 Q4 | 19.66 Thousand CNY | -100.0% |
| 2018 Q3 | 798.3 Million CNY | 0.08% |
| 2018 Q2 | 797.68 Million CNY | 0.08% |
| 2018 Q1 | 797.07 Million CNY | 0.07% |
| 2017 Q1 | 794.76 Million CNY | 0.07% |
| 2017 Q4 | 796.47 Million CNY | 0.07% |
| 2017 Q3 | 795.94 Million CNY | 0.07% |
| 2017 Q2 | 795.34 Million CNY | 0.07% |
| 2017 FY | 796.47 Million CNY | 0.29% |
| 2016 Q3 | 397.07 Million CNY | 0.07% |
| 2016 FY | 794.18 Million CNY | 0.0% |
| 2016 Q4 | 794.18 Million CNY | 100.01% |
| 2016 Q1 | 400 Million CNY | 0.0% |
| 2016 Q2 | 396.78 Million CNY | -0.8% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2011 FY | 3.26 Million CNY | -0.77% |
| 2010 FY | 3.28 Million CNY | -51.88% |
| 2009 FY | 6.83 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 175.94 Million CNY | -782.187% |
| ZJAMP Group Co., Ltd. | 390.5 Million CNY | -297.479% |
| Luyan Pharma Co.,Ltd. | 652.95 Million CNY | -137.714% |
| Ji Yao Holding Group Co., Ltd. | 676.64 Million CNY | -129.393% |